Campath and renal transplant rejection

Area of Science:

• Nephrology
• Transplantation Immunology

Background:

• Acute vascular rejection is a significant complication following renal transplantation.
• Current treatment protocols for this condition remain undefined.

Observation:

• This case report details a single patient's experience with acute vascular rejection post-kidney transplant.
• The patient received a treatment regimen including plasmapheresis, immunoglobulin, and Campath.

Findings:

• The patient demonstrated an initial positive response to the treatment.
• However, the rejection recurred, leading to irreversible graft loss.
• Furthermore, the patient developed post-transplant lymphoproliferative disorder (PTLD).

Implications:

• This case highlights the challenges in managing acute vascular rejection in renal transplant recipients.
• The observed recurrence and subsequent complications underscore the need for refined treatment strategies.
• Further research is warranted to establish effective and safe therapeutic guidelines to prevent graft loss and PTLD.